Synthesis and discovery of polyisopentenylated acylphloroglucinols with selective antiproliferative activity against breast cancer cells
- Bioorg Med Chem Lett. 2027 Jan:142:130785. doi: 10.1016/j.bmcl.2026.130785.
- 1. Yunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, China.
- 2. Department of Gynecology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming 650118, China.
- 3. Yunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, China. Electronic address: [email protected].
- 4. Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China. Electronic address: [email protected].
- 5. Yunnan Key Laboratory of Southern Medicinal Utilization, School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, China; Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China. Electronic address: [email protected].
Twenty-seven polyisopentenylated acylphloroglucinols were designed and synthesized through Friedel-Crafts acylation and alkylation reactions. Among these compounds, a C-farnesylated acylphloroglucinol 13b exhibited selective antiproliferative activity against HER2+ Breast Cancer cells (SKBr3 and JIMT-1) and Triple-Negative Breast Cancer (TNBC) cells (MDA-MB-468), with IC₅₀ values ranging from 7.05 to 9.48 μM. Moreover, compound 13b showed low toxicity toward normal breast epithelial cells MCF-10A (CC₅₀ = 20.1 μM), indicating a favorable safety profile with selectivity indices (SI) ranging from 2.1 to 2.9. Mechanistic studies revealed that 13b inhibits Breast Cancer cell growth by causing G₂/M phase arrest and inducing Apoptosis. These findings provide valuable insights for the development of selective antiproliferative agents against Breast Cancer based on polyisopentenylated acylphloroglucinol scaffold.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer